William A. Denny - Concepedia

Author

William A. Denny

University of Auckland ORCID

Also Known As

Denny, Denny, W.A., Denny, William, Denny, William A., S Davis, W A Denny, W Denny, W. A. DENNY, W. A. Denny, W. Denny

868

Publications

26.4K

Citations

H-Index

179

Concepts

All Affiliations

University of Auckland Cancer Society of New Zealand Maurice Wilkins Centre TB Alliance University of Illinois Chicago

About

William A. Denny is an author at University of Auckland specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	197	9K
2	Natural Sciences	47	170	7.3K
3	Engineering	23	44	1.4K
4	Health Sciences	7	7	399
5	Public Health	1	1	23

William A. Denny

424

Publications

21.6K

Citations

H-Index

Page 1

	Year	Citations
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality Denise A. Chan, Patrick D. Sutphin, Phuong Nguyen, Science Translational Medicine	2011	569
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor David W. Fry, Alexander J. Bridges, William A. Denny, Proceedings of the National Academy of Sciences Drug TargetCell GrowthChemical BiologyMedicinal ChemistrySignaling Pathway	1998	417
Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor Alexander J. Bridges, Hairong Zhou, Donna R. Cody, Journal of Medicinal Chemistry	1996	321
Interactions of antitumor drugs with natural DNA: proton NMR study of binding mode and kinetics Juli Feigon, William A. Denny, Werner Leupin, Journal of Medicinal Chemistry	1984	279
Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions Jeff B. Smaill, Gordon W. Rewcastle, Joseph A. Loo, Journal of Medicinal Chemistry Combinatorial ChemistryOrganic ChemistryPharmacotherapyDermatologyHeterocycle Chemistry	2000	263
RETRACTED: A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation Jharna Datta, Kalpana Ghoshal, William A. Denny, Cancer Research	2009	262
A Molecule Targeting VHL-Deficient Renal Cell Carcinoma that Induces Autophagy Sandra Turcotte, Denise A. Chan, Patrick D. Sutphin, Cancer Cell Cell AutophagyMitophagyMedicineReceptor Tyrosine KinaseAutophagy	2008	252
Mechanism of Action and Preclinical Antitumor Activity of the Novel Hypoxia-Activated DNA Cross-Linking Agent PR-104 Adam V. Patterson, Dianne M. Ferry, Shelley J. Edmunds, Clinical Cancer Research	2007	243
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling Claire Chaussade, Gordon W. Rewcastle, Jackie D. Kendall, Biochemical Journal	2007	225
Two-dimensional proton nuclear magnetic resonance investigation of the synthetic deoxyribonucleic acid decamer d(ATATCGATAT) Juli Feigon, Werner Leupin, William A. Denny, Biochemistry	1983	220

Page 1